Clinical Trials Logo

Xerostomia Due to Radiotherapy clinical trials

View clinical trials related to Xerostomia Due to Radiotherapy.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03743155 Not yet recruiting - Clinical trials for Xerostomia Due to Radiotherapy

Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy

Start date: December 15, 2018
Phase: Phase 2
Study type: Interventional

Phase II not controlled, open-label, prospective, single center clinical trial

NCT ID: NCT03530735 Not yet recruiting - Xerostomia Clinical Trials

Finger-prick Autologous Blood (FAB) for Use in Dry Mouth

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

This is a feasibility study that will assess the efficacy of using autologous blood to treat moderate to severe dry mouth. Dry mouth has been estimated to affect up to 64.8% of the general population (Navazesh et al., 2009) and many patients that are affected by Sjögren's syndrome or have had radiation therapy to combat head or neck cancer (Navazesh et al., 2009). The blood will be applied to the interior of the mouth by means of a mouthwash. This research poses the first potential curative treatment for dry mouth - all other current dry mouth treatments are either symptomatic or lifestyle-based. Autologous blood has been shown to be effective in treating the epithelial surface of dry eyes. This has been attributed to the analogous growth factors in the blood to that of tears - and potentially in this case, saliva - in healing the oral epithelial surface (Herbst et al., 2004).